We’re proud to share that Dr. Chad Gordon, Founder of CraniUS Therapeutics, joined the State of MedTech podcast to discuss how innovation is transforming the future of neurosurgery.

From redefining skull reconstruction to overcoming the blood-brain barrier, Dr. Gordon shares how advances in AI, regenerative medicine, and implantable technology are paving new paths in brain health.

About CraniUS

About CraniUS™

CraniUS™ was founded May 2021 in Baltimore, MD, as a byproduct of the emerging field known as “Neuroplastic and Reconstructive Surgery”, through the vision, insight, and pioneering work of Dr. Chad Gordon. CraniUS™ has raised over $24M to date, been issued 7 patents, and is currently in the midst of a Series B raise.

The NeuroPASS™ device is currently in the pre-clinical development stage and is not yet commercially available. It is on the pathway to clinical studies, and any information provided is subject to change as research progresses.